AC BIOSCIENCE
AC BioScience is a start-up biotech company with an innovative vision and business model. We are dedicated to developing new therapies to fight a range of cancers. Founded by Andreas Schläpfer and Professor Christian Auclair, an internationally recognized expert in molecular oncology, the company is leading a paradigm shift in cancer therapeutics. The company is headquartered at the EPFL Innovation Park near Lausanne, and celebrated its first year of existence in March 2018.
AC BIOSCIENCE
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Ecublens, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.ac-bioscience.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
7.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.ac-bioscience.com
- Host name: 192.131.153.160.host.secureserver.net
- IP address: 160.153.131.192
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "AC BioScience"
AC BioScience - Our company 11.2023
AC BioScience is a pure play in immuno-oncology with focus on the development of its newly discovered drug to enhance the efficacy of Immune-checkpoint inhibitor (ICI) therapy. Read …See details»
AC BioScience - Crunchbase Company Profile & Funding
AC BioScience is a start-up biotech company with an innovative vision and business model. We are dedicated to developing new therapies to fight a range of cancers. Founded by Andreas …See details»
AC BioScience - About us 11.2023
AC BioScience is a start-up biotech company located at the Biopôle life sciences campus near Lausanne and celebrates its seventh year of existence in March 2024. We are pioneering …See details»
AC BioScience SA - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
AC BioScience SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore AC BioScience SA with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, Technology …See details»
AC BioScience - Craft
AC BioScience is a biotech company dedicated to developing therapies to fight a range of cancers. Its neo-adjuvant therapy is designed to improve the efficacy of all types of chemo- …See details»
AC Bioscience SA - Swiss Biotech
AC BioScience Ltd is a pre-clinical stage biotechnology company dedicated to developing innovative therapies for the treatment of tumoral and immunological pathologies. Products, services, technology ACB2112, a molecule in the Azole …See details»
AC BioScience - Funding, Financials, Valuation & Investors
AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
AC BioScience - PitchBook
AC BioScience General Information Description. Operator of a biotechnology company intended to treat tumorous and infectious diseases. The company's products specialize in the protection of the skin and mucous membranes and therapies for the treatment of cancer and also offers ancillary services to achieve a significant increase in the survival rate of patients with specific …See details»
Contact - AC BioScience
Full name *. e-mail *. Company *See details»
AC BioScience - Crunchbase
AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients.See details»
AC Bioscience SA - VentureRadar
AC BioScience's innovative approach is characterized by the way we develop and apply new vascular normalizers that help drugs to better access solid tumors and oxygenation, thereby …See details»
AC BioScience closes a 4th seed-round of CHF 2.5 million
Nov 8, 2024 Founded by Andreas Schlaepfer and Professor Christian Auclair, AC BioSciences develops personalized molecular therapies designed to optimize efficiency or bolster the …See details»
AC BioScience - Strategy 11.2023
AC BioScience has obtained a EUROSTARS grant of € 852 Thousand in 2022 for its multi-partner transnational innovation project. AC BioScience is the lead partner of a consortium that …See details»
ACB-1801 - Drug Targets, Indications, Patents - Synapse - Patsnap
ACB-1801: a Actin modulators Drug, Initially developed by AC BioScience SA, Now, its global highest R&D status is Preclinical, Mechanism: Actin modulators, Therapeutic Areas: …See details»
AC BioScience: Awarded by Investor Network of the EU Institute …
Apr 4, 2022 "We have been delighted to learn that AC BioScience has been awarded Gold status by the Investor Network of the European Institute of Innovation and Technology (EIT). This is a great recognition of the company's compelling science and business case", said Andreas Schläpfer, Co-founder and CEO of AC BioScience. The EIT is a network of best-in-class …See details»
AC BioScience SA at the Swiss Biotech Day
AC BioScience has achieved a breakthrough discovery with its new and proprietary immunomodulating molecule ACB2112. In combination treatments with ICIs, ACB2112 …See details»
The 'Holy Grail' in Immuno-Oncology: AC BioScience SA is
Oct 28, 2020 AC BioScience is a Swiss biotech company based at the EPFL Innovation Park and Biopôle, dedicated to developing groundbreaking therapies to fight a range of cancers and infectious diseases. We are about to start clinical trials with two of four leading-edge cancer drugs mainly focusing on immune-oncology and tumor vascular normalization with multi-billion $ …See details»
AC BioScience - Contacts, Employees, Board Members
Organization. AC BioScience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. AC …See details»
AC BioScience SA at the Swiss Biotech Day
AC Bioscience is pioneering ground-breaking therapeutic solutions to potentiate efficacy of immunotherapy (for colorectal cancer) and normalization of tumor vasculature (for pancreatic cancer) where there is a great unmet medical need.See details»